Opsin 3 Regulates Melanogenesis in Human Congenital Melanocytic Nevus Cells via Functional Interaction with BRAFV600E

Xian Dong,Wen Zeng,Wei Zhang,Yinghua Lan,Yu Wang,Jianglong Feng,Lingxi Gu,Hongguang Lu
DOI: https://doi.org/10.1016/j.jid.2022.04.022
IF: 7.59
2022-01-01
Journal of Investigative Dermatology
Abstract:<h2>ABSTRACT</h2> Opsin3 (OPN3), as a member of the opsin family, has various non-light dependent functions. Congenital melanocytic nevus (CMN) is a skin lesion with dark pigmentation that appears at birth and can be initiated by the BRAF<sup>V600E</sup> mutation in melanocytes. However, the role of OPN3 in BRAF<sup>V600E</sup> congenital melanocytic nevus cell melanogenesis has never been reported. Here, we show that OPN3 acts as a negative regulator of melanin production by modulating BRAF<sup>V600E</sup> signaling in BRAF<sup>V600E</sup> congenital melanocytic nevus cells. Knocking down OPN3 expression can inhibit the BRAF<sup>V600E</sup>/extracellular regulated protein kinase (ERK) signaling pathway and upregulate the expression of microcephaly related transcription factors (MITF), tyrosinase (TYR) and tyrosinase-related proteins 1 and 2 (TRP-1 and TRP-2), thus increasing melanin levels in BRAF<sup>V600E</sup> congenital melanocytic nevus cells. More remarkably, OPN3 and BRAF<sup>V600E</sup> were found to form a physical complex. Furthermore, a 3D nevus model was used to further prove the negative regulatory effect of OPN3 on BRAF<sup>V600E</sup> congenital melanocytic nevus cell melanogenesis. Our study reveals a mechanism for OPN3-mediated melanogenesis in BRAF<sup>V600E</sup> congenital melanocytic nevus cells, and these results may lead to a more personalized and economically viable approach to treating BRAF<sup>V600E</sup> congenital melanocytic nevus.
What problem does this paper attempt to address?